Dysautonomia in chronic fatigue syndrome: Facts, hypotheses, implications

Medical Hypotheses

Volumn 62, Issue 2, 2004, Pages 203-206

  Naschitz, Jochanan E ^a   Yeshurun, Daniel ^a   Rosner, Itzhak ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; MIDODRINE;

AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RESPONSE; CHRONIC FATIGUE SYNDROME; COGNITIVE THERAPY; DIAGNOSTIC ACCURACY; DYSAUTONOMIA; FATIGUE; FRACTAL ANALYSIS; HEAD POSITION; HEMODYNAMIC MONITORING; HEMODYNAMICS; HUMAN; HYPOTHESIS; ORTHOSTATIC HYPOTENSION; PATIENT MONITORING; PATIENT POSITIONING; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STRESS; SYNCOPE; TACHYCARDIA; TREATMENT OUTCOME;

EID: 1342289623     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00331-1     Document Type: Article

References (20)

1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Study Group. Ann Intern Med 1994;121:953-9.
2. Larkins RG, Molesworth SR. Chronic fatigue syndrome - clinical practice guidelines 2002. MJA 2002;176(Suppl 8):S17-55.
3. Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995;274:961-7.
4. Freeman R, Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 1997;102:357-64.
5. Streeten DH, Anderson Jr GH. The role of delayed orthostatic hypotension in the pathogenesis of chronic fatigue. Clin Auton Res 1998;8:119-24.
6. Reid S, Chalder T, Cleare A, Hotopf M, Wesseley S. Chronic fatigue syndrome. BMJ 2000;320:292-6.
7. Whiting P, Bagnall A, Sowden A, Cornell JE, Mulrow CD, Ramirez G. Interventions for the treatment and management of the chronic fatigue syndrome. JAMA 2001;286: 1360-8.
8. Mulrow CD, Ramirez G, Cornell JE, Allsup K. Defining and managing chronic fatigue syndrome. Evidence Report/Technology Assessment No. 42 (Prepared by San Antonio Evidence-based Practice Centre at The University of Texas Health Science Center at San Antonio). AHRQ Publication No. 02-E001. Rockville (MD): Agency for Healthcare Research and Quality; October 2001.
9. DeMeirleir K, Bisbal C, Campine I, DeBecker P, Salehzada T, Demettre E, et al. A 37 kDa 2-5 binding protein as potential biochemical marker for chronic fatigue syndrome. Am J Med 2000;108:99-105.
10. Wieling W, Karemaker JM. Measurement of heart rate and blood pressure to evaluate disturbances in neurocardiovascular control. In: Mathias ChJ, editor. Autonomic failure A textbook of clinical disorders of the autonomic nervous system. 4th ed. Oxford Univeristy Press; 1999. p. 198-210.
11. Naschitz JE, Rosner I, Rosenbaum M, Gaitini L, Bistritzki I, Zuckerman E, et al. The capnography head-up tilt test for evaluation of chronic fatigue syndrome. Semin Arthritis Rheum 2000;30:79-86.
12. DeBecker P, Dendale P, DeMeirleir K, Campine L, Vandenborne K, Hagers Y. Autonomic testing in patients with chronic fatigue syndrome. Am J Med 1998;105: 22S-6S.
13. Parati G, DiRienzo M, Omboni S, Mancia G. Computer analysis of blood pressure and heart rate variability in subjects with normal and abnormal autonomic cardiovascular control. In: Matias CJ, Bannister R, editors. Autonomic failure A textbook of clinical disorders of the autonomic nervous system. 4th ed. Oxford University Press; 1999. p. 211-23.
14. Naschitz JE, Sabo E, Naschitz S, Shaviv N, Rosner I, Rozenbaum M, et al. Hemodynamic instability in chronic fatigue syndrome: indices and diagnostic significance. Semin Arthritis Rheum 2001;31:199-208.
15. Naschitz JE, Sabo E, Naschitz S, Rosner I, Rozenbaum M, Fields M, et al. Hemodynamic instability score in chronic fatigue syndrome (CFS) and non-CFS chronic fatigue. Semin Arthritis Rheum 2002;32:141-8.
16. Naschitz JE, Rozenbaum M, Rosner I, Sabo E, Musafia-Priselac R, Shaviv N, et al. Cardiovascular response to upright tilt in fibromyalgia differs from that in chronic fatigue syndrome. J Rheumatol 2001;28:1356-60.
17. Naschitz JE, Sabo E, Naschitz S, Rozenbaum M, Rosner I, Musafia-Priselac R, et al. Fractal analysis and recurrence quantification analysis of heart rate and pulse transit time for diagnosing chronic fatigue syndrome. Clin Auton Res 2002;12:262-74.
18. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res 1993;37:147-53.
19. Krupp LB, LaRocca NM, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
20. Klingenheben T, Credner S, Hohnloser SH. Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers. Pacing Clin Electrophysiol 1999;22:276-81.